Apixaban and Rocuronium bromide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Apixaban (apixaban) and Rocuronium bromide (rocuronium bromide). Common drug interactions include cardio-respiratory arrest among females and pneumonia among males.
The phase IV clinical study analyzes what interactions people have when they take Apixaban and Rocuronium bromide. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Apixaban?
Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,349 Apixaban users. Check the latest studies of Apixaban.
What is Rocuronium bromide?
Rocuronium bromide has active ingredients of rocuronium bromide. eHealthMe is studying from 5,615 Rocuronium bromide users. Check the latest studies of Rocuronium bromide.
13 people who take Apixaban and Rocuronium bromide together, and have interactions are studied.

What are the common drug interactions of Apixaban and Rocuronium Bromide, by gender? *:
female:
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Kounis syndrome (the concurrence of heart pain with conditions associated with mast cell activation leads to heart muscle damage)
- Pulseless electrical activity
- Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
- Ventricular fibrillation (abnormally irregular heart rhythm)
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Anaphylactic reaction (serious allergic reaction)
- Aneurysm ruptured (expansion of the aneurysm reaches a point where the wall becomes too thin, the aneurysm will rupture)
male:
- Pneumonia
- Post procedural pneumonia
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Blood alkaline phosphatase increased
- Hypertransaminasaemia
- Radiation pneumonitis (inflammation of lung due to radiation)
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
What are the common drug interactions of Apixaban and Rocuronium Bromide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Aneurysm ruptured (expansion of the aneurysm reaches a point where the wall becomes too thin, the aneurysm will rupture)
- Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
60+:
- Pneumonia
- Post procedural pneumonia
- Pulseless electrical activity
- Ventricular fibrillation (abnormally irregular heart rhythm)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Blood alkaline phosphatase increased
- Hypertransaminasaemia
- Radiation pneumonitis (inflammation of lung due to radiation)
- Anaphylactic reaction (serious allergic reaction)
What are the existing conditions these people have? *
- Pain: 5 people, 38.46%
- Anaesthesia: 5 people, 38.46%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 38.46%
- Hypotension (abnormally low blood pressure): 4 people, 30.77%
- Sedation: 4 people, 30.77%
- Infection: 4 people, 30.77%
- Haemorrhage (bleeding): 3 people, 23.08%
- Enlarged Prostate: 3 people, 23.08%
- Hepatitis B: 3 people, 23.08%
- Local Anaesthesia: 3 people, 23.08%
* Approximation only. Some reports may have incomplete information.
Do you take Apixaban and Rocuronium bromide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Apixaban (60,349 reports)
- Rocuronium bromide (5,615 reports)
Browse all drug interactions of Apixaban and Rocuronium bromide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Apixaban:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Rocuronium bromide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Apixaban and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rocuronium bromide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on apixaban and rocuronium bromide (the active ingredients of Apixaban and Rocuronium bromide, respectively), and Apixaban and Rocuronium bromide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Naproxen cause Paranasal Sinus Discomfort? - 15 seconds ago
- Drug interactions of Chlorpheniramine Maleate and Furosemide - 26 seconds ago
- Could Neupogen cause Memory Loss? - 27 seconds ago
- Could Esomeprazole Magnesium cause Oesophageal Varices Haemorrhage? - 37 seconds ago
- Drug interactions of Tobradex and Levothyroxine Sodium - 51 seconds ago
- Could Riboflavin cause Appendicitis? - 59 seconds ago
- Drug interactions of Pataday and Ultram - 59 seconds ago
- Could Clarithromycin cause Infusion Site Swelling? - a minute ago
- Drug interactions of Taxol and Fenofibrate - a minute ago
- Could Cyclosporine cause Gums - Swollen? - a minute ago